Movement Alert｜WuXi XDC Rises 3.34% in Regular Trading, Multiple Major Banks Issue Positive Ratings Boosting Sentiment

Market Focus

Jul 09

On July 9, WuXi XDC rose 3.34% in regular trading, trading at HK$60.4/share, with turnover of HK$40.96 million.

The rally was driven by positive analyst coverage from multiple investment banks. CLSA raised its target price from HK$80.9 to HK$82.6, maintaining an Outperform rating, forecasting strong new project growth in the first half and continued global ADC outsourcing market share gains. CLSA projects revenue growth of 33%, 31%, and 28% for the next three years, with net profit growth of 11%, 51%, and 33% respectively. Separately, Daiwa initiated coverage with a Buy rating and HK$78 target price, naming the company a top pick in Chinas CXO sector, noting its 24% ADC market share and full-chain CRDMO service capabilities.

Within the Life Sciences Tools and Services sector, the broader group showed strength. Among peers, Insilico rose 5.57%, WuXi Biologics rose 4.32%, XtalPi rose 2.86%, WuXi AppTec rose 2.73%, and Pharmaron rose 2.27%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1141339627"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1141339627\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1141339627?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-09 09:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1141339627","market":"us","top_or_hot":-1,"title":"Movement Alert｜WuXi XDC Rises 3.34% in Regular Trading, Multiple Major Banks Issue Positive Ratings Boosting Sentiment","media":"Market Focus","content":"<p><p>On July 9, WuXi XDC rose 3.34% in regular trading, trading at HK$60.4/share, with turnover of HK$40.96 million.</p><p>The rally was driven by positive analyst coverage from multiple investment banks. CLSA raised its target price from HK$80.9 to HK$82.6, maintaining an Outperform rating, forecasting strong new project growth in the first half and continued global ADC outsourcing market share gains. CLSA projects revenue growth of 33%, 31%, and 28% for the next three years, with net profit growth of 11%, 51%, and 33% respectively. Separately, Daiwa initiated coverage with a Buy rating and HK$78 target price, naming the company a top pick in Chinas CXO sector, noting its 24% ADC market share and full-chain CRDMO service capabilities.</p><p>Within the Life Sciences Tools and Services sector, the broader group showed strength. Among peers, Insilico rose 5.57%, WuXi Biologics rose 4.32%, XtalPi rose 2.86%, WuXi AppTec rose 2.73%, and Pharmaron rose 2.27%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜WuXi XDC Rises 3.34% in Regular Trading, Multiple Major Banks Issue Positive Ratings Boosting Sentiment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜WuXi XDC Rises 3.34% in Regular Trading, Multiple Major Banks Issue Positive Ratings Boosting Sentiment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-09 09:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 9, WuXi XDC rose 3.34% in regular trading, trading at HK$60.4/share, with turnover of HK$40.96 million.</p><p>The rally was driven by positive analyst coverage from multiple investment banks. CLSA raised its target price from HK$80.9 to HK$82.6, maintaining an Outperform rating, forecasting strong new project growth in the first half and continued global ADC outsourcing market share gains. CLSA projects revenue growth of 33%, 31%, and 28% for the next three years, with net profit growth of 11%, 51%, and 33% respectively. Separately, Daiwa initiated coverage with a Buy rating and HK$78 target price, naming the company a top pick in Chinas CXO sector, noting its 24% ADC market share and full-chain CRDMO service capabilities.</p><p>Within the Life Sciences Tools and Services sector, the broader group showed strength. Among peers, Insilico rose 5.57%, WuXi Biologics rose 4.32%, XtalPi rose 2.86%, WuXi AppTec rose 2.73%, and Pharmaron rose 2.27%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02268","symbol_name":"药明合联","start_time":0,"source_url":"","article_id":"1141339627","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1141339627","pubTimestamp":1783562143,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 9, WuXi XDC rose 3.34% in regular trading, trading at HK$60.4/share, with turnover of HK$40.96 million.The rally was driven by positive analyst coverage from multiple investment banks. CLSA...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02268":"药明合联"},"translate_title":"动向提示|药明XDC常规交易涨3.34%多家大行发布正面评级提振人气","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02268":1},"content_text":"On July 9, WuXi XDC rose 3.34% in regular trading, trading at HK$60.4/share, with turnover of HK$40.96 million.The rally was driven by positive analyst coverage from multiple investment banks. CLSA raised its target price from HK$80.9 to HK$82.6, maintaining an Outperform rating, forecasting strong new project growth in the first half and continued global ADC outsourcing market share gains. CLSA projects revenue growth of 33%, 31%, and 28% for the next three years, with net profit growth of 11%, 51%, and 33% respectively. Separately, Daiwa initiated coverage with a Buy rating and HK$78 target price, naming the company a top pick in Chinas CXO sector, noting its 24% ADC market share and full-chain CRDMO service capabilities.Within the Life Sciences Tools and Services sector, the broader group showed strength. Among peers, Insilico rose 5.57%, WuXi Biologics rose 4.32%, XtalPi rose 2.86%, WuXi AppTec rose 2.73%, and Pharmaron rose 2.27%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}